Advertisement
UK markets closed
  • FTSE 100

    7,952.62
    +20.64 (+0.26%)
     
  • FTSE 250

    19,884.73
    +74.07 (+0.37%)
     
  • AIM

    743.26
    +1.15 (+0.15%)
     
  • GBP/EUR

    1.1710
    +0.0016 (+0.14%)
     
  • GBP/USD

    1.2639
    +0.0017 (+0.13%)
     
  • Bitcoin GBP

    55,365.40
    -973.58 (-1.73%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • S&P 500

    5,254.35
    +5.86 (+0.11%)
     
  • DOW

    39,807.37
    +47.29 (+0.12%)
     
  • CRUDE OIL

    83.11
    -0.06 (-0.07%)
     
  • GOLD FUTURES

    2,254.80
    +16.40 (+0.73%)
     
  • NIKKEI 225

    40,369.44
    +201.37 (+0.50%)
     
  • HANG SENG

    16,541.42
    +148.58 (+0.91%)
     
  • DAX

    18,492.49
    +15.40 (+0.08%)
     
  • CAC 40

    8,205.81
    +1.00 (+0.01%)
     

EU executive says joint vaccine strategy not unravelling

BRUSSELS, March 2 (Reuters) - The European Union's joint vaccine procurement has not unravelled, a spokesman for the European Commission said on Tuesday when asked about individual countries getting jabs from Russia or China that do not have the bloc's authorisation.

"It's not that the strategy unravelled," Commission spokesman Stefan de Keersmaecker said, adding that EU countries have the right to seal their contracts of their own with producers beyond those the Commission agrees on for the bloc.

"For our vaccines, we go through the European Medicines Agency because we want to ensure efficacy and safety. What member states do in addition to that, it's their responsibility."

De Keersmaecker said emergency authorisations by particular member states may be more risky than the full EMA procedure. (Reporting by Gabriela Baczynska Editing by John Chalmers)